Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

By S. Bhasin, J. Brito, G. Cunningham, F. Hayes, H. Hodis, A. Matsumoto, P. Snyder, R. Swerdloff, Frederick C W Wu, Maria A. Yialamas. Journal of Clinical Endocrinology and Metabolism, 2018

1,415 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/f3b49a5d8d7d94116be23d8bdfa446dad7ece34d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Çilesiz
2. S. I. Bolleddu
3. M. Gül
4. S. Minhas
5. K. Dimitropolous
6. Kinjal Shah
7. J. Carvalho
8. J. I. Martinez Salamanca

Citations in the corpus

• Cardiovascular Risks Associated with Gender and Aging (2019, background): “While a majority of men show diminished testosterone levels with advanced age, these levels are still considered within the normal physiological range, without symptoms of androgen deficiency and hypogonadism [148].”
• European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction. (2021, background): “5 ng/dl) are associated with hypogonadal symptoms (Table 1) [7,26,27].”